Erin Duralde, MD

Dr. Erin Duralde is driven to help people live well and unburdened by illness throughout the life course. She received her MD from the University of California, San Francisco and completed internal medicine primary care residency at Beth Israel Deaconess Medical Center (BIDMC). She is currently a Mass General Brigham Population Health Leadership Fellow. During her residency, Dr. Duralde maintained clinics at both BIDMC’s academic primary care practice and Fenway Health, a federally qualified health center and leader in LGBTQ+ care. She co-founded the BIDMC Innovation Group, an organization dedicated to providing community and training for residents interested in improving healthcare delivery through innovations in technology, business, and health systems.

During medical school, Dr. Duralde conducted research in urinary incontinence and sexual function in women and developed a novel graphical survey instrument of erogenous anatomy with urology colleagues for use in research. She presented her research at the International Society for the Study of Women’s Sexual Health among other conferences and published several articles. While at BIDMC, her research focused on investigating disparities in ICU clinical trajectories toward end of life, as well as the determinants of patient retention and loss in an academic primary care practice. She is a staunch advocate for the LGBTQ+ community and was part of a successful campaign to change BIDMC’s electronic medical records system to correctly identify gender-diverse patients.

While at the Brigham, Dr. Duralde is training under Dr. Heather Hirsch’s mentorship in the Menopause and Midlife Clinic at the Fish Center as well as providing urgent care at the Jen Center for primary care. 

Brigham & Women’s Hospital
Associate Physician, Division of Women’s Health, Department of Medicine
Harvard Medical School
Instructor in Medicine
Mass General Brigham
Population Health Leadership Fellow

Areas of Expertise

Current Research

Predictors of patient retention in primary care.
Influence of estrogen therapy on cancer recurrence risk.

Select Past Research

  • Urinary incontinence and sexual dysfunction in women
  • Treatment seeking for urinary incontinence
  • Fertility, menopause, and body image in breast cancer survivorship

Select Publications

Duralde ER, Rowen T. Urinary Incontinence and Associated Female Sexual Dysfunction. Sex Med Rev 2017 Oct;5(4): 470-485. PMID: 28827036


Duralde ER, Walter LC, Van Den Eeden SK, Nakagawa S, Subak LL, Brown JS, Thom DH, Huang AJ. Bridging the gap: determinants of undiagnosed or untreated urinary incontinence in women. Am J Obstet Gynecol. 2016 Feb;214(2): 266.e1-266.e9. PMID: 26348382


Chien AJ,Duralde E, Hwang R, Tsung K, Kao CN, Rugo HS, Melisko ME, Esserman LJ, Munster PN, Cedars M, Kerlikowske K, McCulloch CE, Rosen MP. Association of tamoxifen use and ovarian function in patients with invasive or pre-invasive breast cancer. Breast Cancer Res Treat. 2015 Aug;153(1): 173-81. PMID:26208485


Peled AW,Duralde E, Foster RD, Fiscalini AS, Esserman LJ, Hwang ES, Sbitany H. Patient-reported outcomes and satisfaction after total skin-sparing mastectomy and immediate expander-implant reconstruction. Ann Plast Surg. 2014 May;72 Suppl 1: S48-52. PMID: 24317238